UiPath (NYSE:PATH) Stock Price Down 1.9%

UiPath Inc. (NYSE:PATH - Get Free Report) was down 1.9% during mid-day trading on Friday . The company traded as low as $20.83 and last traded at $20.91. Approximately 1,477,355 shares traded hands during trading, a decline of 84% from the average daily volume of 9,013,123 shares. The stock had previously closed at $21.31.

Analyst Ratings Changes

Several equities analysts have issued reports on PATH shares. Evercore ISI increased their price objective on shares of UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a report on Thursday, March 14th. Scotiabank increased their price objective on shares of UiPath from $29.00 to $30.00 and gave the company a "sector perform" rating in a report on Thursday, March 14th. BMO Capital Markets increased their price objective on shares of UiPath from $24.00 to $28.00 and gave the company a "market perform" rating in a report on Thursday, March 14th. KeyCorp started coverage on shares of UiPath in a report on Monday. They set an "overweight" rating and a $27.00 price objective on the stock. Finally, Morgan Stanley increased their price objective on shares of UiPath from $17.00 to $25.00 and gave the company an "equal weight" rating in a report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, UiPath currently has a consensus rating of "Moderate Buy" and an average price target of $27.41.

UiPath Stock Down 2.9 %

The stock has a market capitalization of $11.78 billion, a price-to-earnings ratio of -122.99 and a beta of 0.96. The company's 50-day moving average is $23.35 and its 200-day moving average is $21.33.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million during the quarter, compared to analysts' expectations of $383.32 million. Sell-side analysts anticipate that UiPath Inc. will post -0.04 EPS for the current year.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now owns 660,762 shares of the company's stock, valued at $14,312,104.92. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last ninety days, insiders sold 72,000 shares of company stock worth $1,591,360. Insiders own 31.03% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PATH. Mark Sheptoff Financial Planning LLC purchased a new position in UiPath during the fourth quarter worth about $25,000. HighMark Wealth Management LLC purchased a new position in UiPath during the fourth quarter worth about $27,000. Tyler Stone Wealth Management purchased a new position in UiPath during the second quarter worth about $28,000. Cypress Capital Management LLC WY purchased a new position in shares of UiPath in the fourth quarter valued at approximately $29,000. Finally, Fifth Third Bancorp grew its holdings in shares of UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock valued at $34,000 after purchasing an additional 1,905 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.